Novanta Inc. (NASDAQ:NOVT) CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction on Monday, April 5th. The shares were sold at an average price of $135.43, for a total transaction of $1,015,725.00. Following the transaction, the chief executive officer now directly owns 127,833 shares of the company’s stock, valued at $17,312,423.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Novanta stock opened at $134.18 on Thursday. Novanta Inc. has a 52-week low of $75.87 and a 52-week high of $146.16. The company has a quick ratio of 1.51, a current ratio of 2.27 and a debt-to-equity ratio of 0.42. The firm’s fifty day moving average is $132.46 and its 200 day moving average is $123.28. The company has a market cap of $4.75 billion, a price-to-earnings ratio of 115.67 and a beta of 1.09.
Novanta (NASDAQ:NOVT) last announced its earnings results on Sunday, February 28th. The technology company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.09. The firm had revenue of $147.50 million for the quarter, compared to analysts’ expectations of $147.05 million. Novanta had a net margin of 6.81% and a return on equity of 16.33%. The business’s revenue was down 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.55 EPS. On average, equities research analysts anticipate that Novanta Inc. will post 1.85 earnings per share for the current fiscal year.
Several research analysts have commented on NOVT shares. Zacks Investment Research downgraded shares of Novanta from a “hold” rating to a “sell” rating in a report on Thursday, March 4th. TheStreet upgraded Novanta from a “c+” rating to a “b” rating in a report on Monday, March 1st.
Novanta Company Profile
Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Recommended Story: Hold Rating
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.